Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine
    Published on 2023-07-12
    3 years ago
  • Are novel treatments for brain disorders hiding in plain sight?
    Published on 2023-07-08
    3 years ago
  • Closing the loop in psychiatric deep brain stimulation: physiology, psychometrics, and plasticity
    Published on 2023-07-06
    3 years ago
  • Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior
    Published on 2023-07-05
    3 years ago
  • Atypical cortical networks in children at high-genetic risk of psychiatric and neurodevelopmental disorders
    Published on 2023-07-04
    3 years ago
  • Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice
    Published on 2023-07-03
    3 years ago
  • Blocking μ-opioid receptors attenuates reinstatement of responding to an alcohol-predictive conditioned stimulus through actions in the ventral hippocampus
    Published on 2023-07-01
    3 years ago
« Previous 1 … 130 131 132 133 134 … 143 Next »
Journal of Psychopharmacology
  • Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking
    Published on 2019-11-06
    7 years ago
  • Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication
    Published on 2019-11-06
    7 years ago
  • Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians
    Published on 2019-11-05
    7 years ago
  • Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users
    Published on 2019-11-04
    7 years ago
  • Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABAA receptors
    Published on 2019-10-31
    7 years ago
  • Lithium-associated hypothyroidism and potential for reversibility after lithium discontinuation: Findings from the LiSIE retrospective cohort study
    Published on 2019-10-31
    7 years ago
  • Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration
    Published on 2019-10-23
    7 years ago
« Previous 1 … 130 131 132 133 134 … 154 Next »
European Neuropsychopharmacology
  • Maternal immune activation in rats attenuates the excitability of monoamine-secreting neurons in adult offspring in a sex-specific way
    Published on 2020-12-17
    6 years ago
  • Central levels of tryptophan metabolites in subjects with bipolar disorder
    Published on 2020-12-16
    6 years ago
  • Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice
    Published on 2020-12-16
    6 years ago
  • Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine
    Published on 2020-12-11
    6 years ago
  • Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up
    Published on 2020-12-11
    6 years ago
  • Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig
    Published on 2020-12-05
    6 years ago
  • Abstinence from ethanol dependence produces concomitant cortical gray matter abnormalities, microstructural deficits and cognitive dysfunction
    Published on 2020-12-03
    6 years ago
« Previous 1 … 130 131 132 133 134 … 170 Next »

   Pharma Pub